Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

1.

Erratum: Longer hospital stay is associated with high rates of tuberculosis-related morbidity and mortality within 12 months after discharge in a referral hospital in Sub-Saharan Africa.

Zetola NM, Macesic N, Shin SS, Peloso A, Ncube R, Klausner JD, Modongo C, Collman RG.

BMC Infect Dis. 2015 May 10;15:211. doi: 10.1186/s12879-015-0942-8. No abstract available.

2.

Persistent high mortality in advanced HIV/TB despite appropriate antiretroviral and antitubercular therapy: an emerging challenge.

Bisson GP, Zetola N, Collman RG.

Curr HIV/AIDS Rep. 2015 Mar;12(1):107-16. doi: 10.1007/s11904-015-0256-x.

PMID:
25772785
3.

Successful MDR-TB treatment regimens including amikacin are associated with high rates of hearing loss.

Modongo C, Sobota RS, Kesenogile B, Ncube R, Sirugo G, Williams SM, Zetola NM.

BMC Infect Dis. 2014 Oct 9;14:542. doi: 10.1186/1471-2334-14-542.

4.

Co-infection with HPV types from the same species provides natural cross-protection from progression to cervical cancer.

Sobota RS, Ramogola-Masire D, Williams SM, Zetola NM.

Infect Agent Cancer. 2014 Aug 12;9:26. doi: 10.1186/1750-9378-9-26. eCollection 2014.

5.

Advanced immune suppression is associated with increased prevalence of mixed-strain Mycobacterium tuberculosis infections among persons at high risk for drug-resistant tuberculosis in Botswana.

Shin SS, Modongo C, Ncube R, Sepako E, Klausner JD, Zetola NM.

J Infect Dis. 2015 Feb 1;211(3):347-51. doi: 10.1093/infdis/jiu421. Epub 2014 Jul 28.

PMID:
25070941
6.

Invasive cervical cancers from women living in the United States or Botswana: differences in human papillomavirus type distribution.

Ermel A, Ramogola-Masire D, Zetola N, Tong Y, Qadadri B, Azar MM, Brown DR.

Infect Agent Cancer. 2014 Jul 8;9:22. doi: 10.1186/1750-9378-9-22. eCollection 2014.

8.

Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes.

Zetola NM, Shin SS, Tumedi KA, Moeti K, Ncube R, Nicol M, Collman RG, Klausner JD, Modongo C.

J Clin Microbiol. 2014 Jul;52(7):2422-9. doi: 10.1128/JCM.02489-13. Epub 2014 Apr 30.

9.

Clinical outcomes among persons with pulmonary tuberculosis caused by Mycobacterium tuberculosis isolates with phenotypic heterogeneity in results of drug-susceptibility tests.

Zetola NM, Modongo C, Moonan PK, Ncube R, Matlhagela K, Sepako E, Collman RG, Bisson GP.

J Infect Dis. 2014 Jun 1;209(11):1754-63. doi: 10.1093/infdis/jiu040. Epub 2014 Jan 16.

10.

Examining the relationship between alcohol use and high-risk sex practices in a population of women with high HIV incidence despite high levels of HIV-related knowledge.

Zetola NM, Modongo C, Olabiyi B, Ramogola-Masire D, Collman RG, Chao LW.

Sex Transm Infect. 2014 May;90(3):216-22. doi: 10.1136/sextrans-2013-051244. Epub 2014 Jan 15.

11.

Info-gap management of public health Policy for TB with HIV-prevalence and epidemiological uncertainty.

Ben-Haim Y, Dacso CC, Zetola NM.

BMC Public Health. 2012 Dec 19;12:1091. doi: 10.1186/1471-2458-12-1091.

12.

Leveraging a rapid, round-the-clock HIV testing system to screen for acute HIV infection in a large urban public medical center.

Christopoulos KA, Zetola NM, Klausner JD, Haller B, Louie B, Hare CB, Pandori M, Nassos P, Roemer M, Pilcher CD.

J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):e30-8. doi: 10.1097/QAI.0b013e31827a0b0d.

13.

Prevalence of hypothyroidism among MDR-TB patients in Botswana.

Modongo C, Zetola NM.

Int J Tuberc Lung Dis. 2012 Nov;16(11):1561-2. doi: 10.5588/ijtld.12.0403. No abstract available.

14.

Measuring stigma: are we looking in the right places?

Zetola NM, Olabiyi B, Ramogola-Masire D, Modongo C.

Int J Tuberc Lung Dis. 2012 Aug;16(8):1130-1. doi: 10.5588/ijtld.11.0824. No abstract available.

15.

Male circumcision reduces human papillomavirus incidence and prevalence: clarifying the evidence.

Zetola N, Klausner JD.

Sex Transm Dis. 2012 Feb;39(2):114-5. doi: 10.1097/OLQ.0b013e318242b4f3. No abstract available.

PMID:
22249299
16.

Cervical cancer prevention in HIV-infected women using the "see and treat" approach in Botswana.

Ramogola-Masire D, de Klerk R, Monare B, Ratshaa B, Friedman HM, Zetola NM.

J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):308-13. doi: 10.1097/QAI.0b013e3182426227.

17.

Subtype distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana.

Ramogola-Masire D, McGrath CM, Barnhart KT, Friedman HM, Zetola NM.

Int J Gynecol Pathol. 2011 Nov;30(6):591-6. doi: 10.1097/PGP.0b013e31821bf2a6.

18.

Spread of extensively drug-resistant tuberculosis in KwaZulu-Natal province, South Africa.

Moodley P, Shah NS, Tayob N, Connolly C, Zetola N, Gandhi N, Friedland G, Sturm AW.

PLoS One. 2011;6(5):e17513. doi: 10.1371/journal.pone.0017513. Epub 2011 May 31.

19.

Has the answer to diagnosing TB in resource-limited settings been found?

Modongo C, Zetola NM, Pandori M, Klausner JD.

MLO Med Lab Obs. 2011 Mar;43(3):25. No abstract available.

20.

Survey of childhood blindness and visual impairment in Botswana.

Nallasamy S, Anninger WV, Quinn GE, Kroener B, Zetola NM, Nkomazana O.

Br J Ophthalmol. 2011 Oct;95(10):1365-70. doi: 10.1136/bjo.2010.189068. Epub 2011 Jan 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk